Mark A. Bach

2.4k total citations
42 papers, 1.9k citations indexed

About

Mark A. Bach is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark A. Bach has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark A. Bach's work include Growth Hormone and Insulin-like Growth Factors (17 papers), Metabolism, Diabetes, and Cancer (8 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Mark A. Bach is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (17 papers), Metabolism, Diabetes, and Cancer (8 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Mark A. Bach collaborates with scholars based in United States, Denmark and Belgium. Mark A. Bach's co-authors include Carolyn A. Bondy, Charles T. Roberts, Derek LeRoith, Bethel Stannard, Suzan S. Pezzoli, Michael O. Thorner, Jennifer Ng, David Krupa, D. Plotkin and Zila Shen‐Orr and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mark A. Bach

41 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Bach United States 23 859 466 422 309 304 42 1.9k
Erica Sarchielli Italy 29 1.0k 1.2× 391 0.8× 241 0.6× 90 0.3× 560 1.8× 68 2.3k
W. Teller Germany 22 608 0.7× 509 1.1× 660 1.6× 639 2.1× 65 0.2× 107 2.2k
Alessandra Vottero Italy 27 895 1.0× 811 1.7× 576 1.4× 208 0.7× 74 0.2× 49 2.5k
Paolo Comeglio Italy 32 1.0k 1.2× 442 0.9× 232 0.5× 97 0.3× 648 2.1× 96 2.8k
Ilaria Cellai Italy 28 965 1.1× 456 1.0× 263 0.6× 68 0.2× 458 1.5× 67 2.0k
Clara Crescioli Italy 30 472 0.5× 747 1.6× 197 0.5× 53 0.2× 220 0.7× 77 2.4k
Alessandra Cassio Italy 28 1.3k 1.6× 868 1.9× 137 0.3× 171 0.6× 80 0.3× 103 2.3k
Christiane Coussieu France 24 482 0.6× 866 1.9× 704 1.7× 147 0.5× 56 0.2× 47 2.7k
Michael E. DiSanto United States 24 534 0.6× 510 1.1× 236 0.6× 44 0.1× 907 3.0× 99 2.0k
M. Ziegler Germany 26 564 0.7× 899 1.9× 196 0.5× 126 0.4× 151 0.5× 181 2.5k

Countries citing papers authored by Mark A. Bach

Since Specialization
Citations

This map shows the geographic impact of Mark A. Bach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Bach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Bach more than expected).

Fields of papers citing papers by Mark A. Bach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Bach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Bach. The network helps show where Mark A. Bach may publish in the future.

Co-authorship network of co-authors of Mark A. Bach

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Bach. A scholar is included among the top collaborators of Mark A. Bach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Bach. Mark A. Bach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Desjardins, Claude, Mark A. Bach, Anne Rentoumis Cappola, Ellen W. Seely, & Ronald G. Ehrenberg. (2011). Dissecting the Workforce and Workplace for Clinical Endocrinology, and the Work of Endocrinologists Early in Their Careers. The Journal of Clinical Endocrinology & Metabolism. 96(4). 923–933. 3 indexed citations
4.
Bach, Mark A., Kenneth Rockwood, Carl Zetterberg, et al.. (2004). The Effects of MK‐0677, an Oral Growth Hormone Secretagogue, in Patients with Hip Fracture. Journal of the American Geriatrics Society. 52(4). 516–523. 56 indexed citations
5.
Murphy, M. Gail, Mark A. Bach, D. Plotkin, et al.. (1999). Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults. Journal of Bone and Mineral Research. 14(7). 1182–1188. 39 indexed citations
6.
Jette, Alan M., et al.. (1999). Are Performance-Based Measures Sufficiently Reliable for Use in Multicenter Trials?. The Journals of Gerontology Series A. 54(1). M3–M6. 136 indexed citations
7.
Schäfer, Werner, Teuvo L.J. Tammela, David M. Barrett, et al.. (1999). IMPROVEMENT OF PRESSURE FLOW PARAMETERS WITH FINASTERIDE IS GREATER IN MEN WITH LARGE PROSTATES. The Journal of Urology. 161(5). 1513–1517. 29 indexed citations
8.
Schäfer, Werner, Teuvo L.J. Tammela, David M. Barrett, et al.. (1999). Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years. Urology. 54(2). 278–283. 22 indexed citations
9.
Tammela, Teuvo L.J., David M. Barrett, Paul Abrams, et al.. (1999). Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement. Neurourology and Urodynamics. 18(1). 17–24. 40 indexed citations
10.
Oesterling, Joseph E., Johnny Roy, Torben Krarup, et al.. (1998). Biologic Variability of Prostate-Specific Antigen and its Usefulness as a Marker for Prostate Cancer: Effects of Finasteride. Urology. 51(4). 58–63. 9 indexed citations
11.
Fuh, Vivian L. & Mark A. Bach. (1998). Growth hormone secretagogues:mechanism of action and use in aging. Growth Hormone & IGF Research. 8(1). 13–20. 17 indexed citations
12.
Oesterling, Joseph E., Johnny Roy, Torben Krarup, et al.. (1997). Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: Effects of finasteride. Urology. 50(1). 13–18. 43 indexed citations
13.
Chapman, Ian, Mark A. Bach, Eve Van Cauter, et al.. (1996). Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.. The Journal of Clinical Endocrinology & Metabolism. 81(12). 4249–4257. 199 indexed citations
14.
Bondy, Carolyn A., L E Underwood, David R. Clemmons, et al.. (1994). Clinical Uses of Insulin-like Growth Factor I. Annals of Internal Medicine. 120(7). 593–601. 108 indexed citations
15.
Bach, Mark A. & Carolyn A. Bondy. (1992). Anatomy of the pituitary insulin-like growth factor system.. Endocrinology. 131(6). 2588–2594. 80 indexed citations
16.
Bach, Mark A.. (1992). Anatomy of the pituitary insulin-like growth factor system. Endocrinology. 131(6). 2588–2594. 33 indexed citations
17.
Bach, Mark A., Denise Blum, Susan R. Rose, & Lawrence Charnas. (1992). Myalgia and elevated creatine kinase activity associated with subcutaneous injections of diluent. The Journal of Pediatrics. 121(4). 650–651. 11 indexed citations
18.
Werner, Haim, Bethel Stannard, Mark A. Bach, Charles T. Roberts, & Derek LeRoith. (1991). Regulation of Insulin-Like Growth Factor I Receptor Gene Expression in Normal and Pathological States. Advances in experimental medicine and biology. 293. 263–272. 19 indexed citations
19.
Werner, Haim, Bethel Stannard, Mark A. Bach, Derek LeRoith, & Charles T. Roberts. (1990). Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene. Biochemical and Biophysical Research Communications. 169(3). 1021–1027. 73 indexed citations
20.
Bach, Mark A., Enrique Beckmann, & Daniel Levitt. (1984). Pneumococcal cell wall phosphorylcholine elicits polyclonal antibody secretion in mice. European Journal of Immunology. 14(7). 589–594. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erica Sarchielli Breakdown of academic impact, for papers by W. Teller Breakdown of academic impact, for papers by Alessandra Vottero Breakdown of academic impact, for papers by Paolo Comeglio Breakdown of academic impact, for papers by Ilaria Cellai Breakdown of academic impact, for papers by Clara Crescioli Breakdown of academic impact, for papers by Alessandra Cassio Breakdown of academic impact, for papers by Christiane Coussieu Breakdown of academic impact, for papers by Michael E. DiSanto Breakdown of academic impact, for papers by M. Ziegler
Rankless by CCL
2026